Patent ID: 11918597
Assignee: LUNELLA BIOTECH, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 14:
15. A method for delaying the onset of senescence in a patient, the method comprising: inhibiting mitochondrial biogenesis in a plurality of senescent cells in the patient with a first therapeutic agent that targets the large mitochondrial ribosome, inhibiting mitochondrial biogenesis in the plurality of senescent cells with a second therapeutic agent and targets the small mitochondrial ribosome, and inducing mitochondrial oxidative stress in the plurality of senescent cells with a third therapeutic agent; wherein at least one therapeutic agent comprises a conjugate with a TPP moiety; and wherein the first therapeutic agent, the second therapeutic agent, and the third therapeutic agent are administered simultaneously to the patient.